{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T11:07:52Z","timestamp":1762340872776},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,7]],"date-time":"2016-10-07T00:00:00Z","timestamp":1475798400000},"content-version":"vor","delay-in-days":645,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Therapy - Nucleic Acids"],"published-print":{"date-parts":[[2015]]},"DOI":"10.1038\/mtna.2015.40","type":"journal-article","created":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T16:21:11Z","timestamp":1448986871000},"page":"e265","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["CD40 Generation 2.5 Antisense Oligonucleotide Treatment Attenuates Doxorubicin-induced Nephropathy and Kidney Inflammation"],"prefix":"10.1016","volume":"4","author":[{"given":"Aaron J","family":"Donner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steve T","family":"Yeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gene","family":"Hung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark J","family":"Graham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosanne M","family":"Crooke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam E","family":"Mullick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1038\/mtna.2015.40_bib1","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1001\/jama.298.17.2038","article-title":"Prevalence of chronic kidney disease in the United States","volume":"298","author":"Coresh","year":"2007","journal-title":"JAMA"},{"key":"10.1038\/mtna.2015.40_bib2","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1517\/17460441.2014.956075","article-title":"New renal drug development to face chronic renal disease","volume":"9","author":"Moll","year":"2014","journal-title":"Expert Opin Drug Discov"},{"key":"10.1038\/mtna.2015.40_bib3","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0344-0338(11)81021-6","article-title":"The consequences of tubulo-interstitial changes for renal function in glomerulopathies. A morphometric and cytological analysis","volume":"186","author":"Bohle","year":"1990","journal-title":"Pathol Res Pract"},{"key":"10.1038\/mtna.2015.40_bib4","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/BF02786323","article-title":"The CD40 ligand. At the center of the immune universe?","volume":"16","author":"Grewal","year":"1997","journal-title":"Immunol Res"},{"key":"10.1038\/mtna.2015.40_bib5","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1172\/JCI7014","article-title":"The soluble CD40 ligand sCD154 in systemic lupus erythematosus","volume":"104","author":"Kato","year":"1999","journal-title":"J Clin Invest"},{"key":"10.1038\/mtna.2015.40_bib6","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/28204","article-title":"Reduction of atherosclerosis in mice by inhibition of CD40 signalling","volume":"394","author":"Mach","year":"1998","journal-title":"Nature"},{"key":"10.1038\/mtna.2015.40_bib7","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1056\/NEJMoa022600","article-title":"Soluble CD40 ligand in acute coronary syndromes","volume":"348","author":"Heeschen","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1038\/mtna.2015.40_bib8","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.0105-2896.2009.00862.x","article-title":"Gene discovery in rheumatoid arthritis highlights the CD40\/NF-kappaB signaling pathway in disease pathogenesis","volume":"233","author":"Criswell","year":"2010","journal-title":"Immunol Rev"},{"key":"10.1038\/mtna.2015.40_bib9","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.smim.2009.05.011","article-title":"Macrophage CD40 signaling: a pivotal regulator of disease protection and pathogenesis","volume":"21","author":"Suttles","year":"2009","journal-title":"Semin Immunol"},{"key":"10.1038\/mtna.2015.40_bib10","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1136\/gut.2003.026278","article-title":"The CD40\/CD40L costimulatory pathway in inflammatory bowel disease","volume":"53","author":"Danese","year":"2004","journal-title":"Gut"},{"key":"10.1038\/mtna.2015.40_bib11","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1097\/01.ASN.0000091381.60059.FB","article-title":"Intrinsic renal cell expression of CD40 directs Th1 effectors inducing experimental crescentic glomerulonephritis","volume":"14","author":"Ruth","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/mtna.2015.40_bib12","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/ki.1997.102","article-title":"Possible role for CD40-CD40L in the regulation of interstitial infiltration in the kidney","volume":"51","author":"van Kooten","year":"1997","journal-title":"Kidney Int"},{"key":"10.1038\/mtna.2015.40_bib13","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1681\/ASN.V11112044","article-title":"Interleukin-17 and CD40-ligand synergistically enhance cytokine and chemokine production by renal epithelial cells","volume":"11","author":"Woltman","year":"2000","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/mtna.2015.40_bib14","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/art.1780400117","article-title":"Immunohistologic analysis of renal CD40 and CD40L expression in lupus nephritis and other glomerulonephritides","volume":"40","author":"Yellin","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1038\/mtna.2015.40_bib15","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/ki.1995.314","article-title":"Inhibition of the CD40-CD40ligand pathway prevents murine membranous glomerulonephritis","volume":"48","author":"Biancone","year":"1995","journal-title":"Kidney Int"},{"key":"10.1038\/mtna.2015.40_bib16","doi-asserted-by":"crossref","first-page":"3159","DOI":"10.4049\/jimmunol.157.7.3159","article-title":"Anti-CD40 ligand antibody treatment prevents the development of lupus-like nephritis in a subset of New Zealand black x New Zealand white mice. Response correlates with the absence of an anti-antibody response","volume":"157","author":"Early","year":"1996","journal-title":"J Immunol"},{"key":"10.1038\/mtna.2015.40_bib17","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.4049\/jimmunol.160.5.2158","article-title":"Anti-CD40 ligand antibody treatment of SNF1 mice with established nephritis: preservation of kidney function","volume":"160","author":"Kalled","year":"1998","journal-title":"J Immunol"},{"key":"10.1038\/mtna.2015.40_bib18","doi-asserted-by":"crossref","first-page":"e65068","DOI":"10.1371\/journal.pone.0065068","article-title":"CD40 gene silencing reduces the progression of experimental lupus nephritis modulating local milieu and systemic mechanisms","volume":"8","author":"Ripoll","year":"2013","journal-title":"PLoS One"},{"key":"10.1038\/mtna.2015.40_bib19","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1038\/gt.2011.39","article-title":"In vivo therapeutic efficacy of intra-renal CD40 silencing in a model of humoral acute rejection","volume":"18","author":"Ripoll","year":"2011","journal-title":"Gene Ther"},{"key":"10.1038\/mtna.2015.40_bib20","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1046\/j.1523-1755.2003.00223.x","article-title":"Blockade of CD40-CD40 ligand protects against renal injury in chronic proteinuric renal disease","volume":"64","author":"Kairaitis","year":"2003","journal-title":"Kidney Int"},{"key":"10.1038\/mtna.2015.40_bib21","doi-asserted-by":"crossref","first-page":"256ra136","DOI":"10.1126\/scitranslmed.3008538","article-title":"A circulating antibody panel for pretransplant prediction of FSGS recurrence after kidney transplantation","volume":"6","author":"Delville","year":"2014","journal-title":"Sci Transl Med"},{"key":"10.1038\/mtna.2015.40_bib22","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1111\/j.1600-6143.2009.02749.x","article-title":"4D11: The Second Mouse?","volume":"9","author":"Kirk","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1038\/mtna.2015.40_bib23","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1191\/0961203304lu1032oa","article-title":"Lessons learned from anti-CD40L treatment in systemic lupus erythematosus patients","volume":"13","author":"Sidiropoulos","year":"2004","journal-title":"Lupus"},{"key":"10.1038\/mtna.2015.40_bib24","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1111\/ajt.12678","article-title":"Characterization of ASKP1240, a fully human antibody targeting human CD40 with potent immunosuppressive effects","volume":"14","author":"Okimura","year":"2014","journal-title":"Am J Transplant"},{"key":"10.1038\/mtna.2015.40_bib25","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1089\/nat.2013.0443","article-title":"Characterization of target mRNA reduction through in situ RNA hybridization in multiple organ systems following systemic antisense treatment in animals","volume":"23","author":"Hung","year":"2013","journal-title":"Nucleic Acid Ther"},{"key":"10.1038\/mtna.2015.40_bib26","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1046\/j.1523-1755.2000.00342.x","article-title":"Progressive adriamycin nephropathy in mice: sequence of histologic and immunohistochemical events","volume":"58","author":"Wang","year":"2000","journal-title":"Kidney Int"},{"key":"10.1038\/mtna.2015.40_bib27","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1093\/ndt\/gfp569","article-title":"The CD40-CD154 co-stimulation pathway mediates innate immune injury in adriamycin nephrosis","volume":"25","author":"Lee","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/mtna.2015.40_bib28","doi-asserted-by":"crossref","first-page":"H631","DOI":"10.1152\/ajpheart.00733.2005","article-title":"Differential expression and regulation of murine CD40 in regional vascular beds","volume":"290","author":"Vowinkel","year":"2006","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1038\/mtna.2015.40_bib29","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s00418-008-0452-5","article-title":"The renal cortical interstitium: morphological and functional aspects","volume":"130","author":"Kaissling","year":"2008","journal-title":"Histochem Cell Biol"},{"key":"10.1038\/mtna.2015.40_bib30","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1093\/ndt\/gfu076","article-title":"Dendritic cells in progressive renal disease: some answers, many questions","volume":"29","author":"Kitching","year":"2014","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/mtna.2015.40_bib31","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ajpath.2011.09.039","article-title":"Renal dendritic cells adopt a pro-inflammatory phenotype in obstructive uropathy to activate T cells but do not directly contribute to fibrosis","volume":"180","author":"Snelgrove","year":"2012","journal-title":"Am J Pathol"},{"key":"10.1038\/mtna.2015.40_bib32","doi-asserted-by":"crossref","first-page":"3624","DOI":"10.1182\/blood-2008-03-143305","article-title":"CD40: an upstream master switch for endothelial cell activation uncovered by RNAi-coupled transcriptional profiling","volume":"112","author":"Pluvinet","year":"2008","journal-title":"Blood"},{"key":"10.1038\/mtna.2015.40_bib33","doi-asserted-by":"crossref","first-page":"18055","DOI":"10.1074\/jbc.M111.333989","article-title":"Functional interaction of CD154 protein with \u03b15\u03b21 integrin is totally independent from its binding to \u03b1IIb\u03b23 integrin and CD40 molecules","volume":"287","author":"El Fakhry","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1038\/mtna.2015.40_bib34","doi-asserted-by":"crossref","first-page":"3218","DOI":"10.4049\/jimmunol.1500922","article-title":"Interaction of Macrophage Antigen 1 and CD40 Ligand Leads to IL-12 Production and Resistance in CD40-Deficient Mice Infected with Leishmania major","volume":"195","author":"Okwor","year":"2015","journal-title":"J Immunol"},{"key":"10.1038\/mtna.2015.40_bib35","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1161\/CIRCRESAHA.111.247684","article-title":"Binding of CD40L to Mac-1's I-domain involves the EQLKKSKTL motif and mediates leukocyte recruitment and atherosclerosis\u2013but does not affect immunity and thrombosis in mice","volume":"109","author":"Wolf","year":"2011","journal-title":"Circ Res"},{"key":"10.1038\/mtna.2015.40_bib36","doi-asserted-by":"crossref","first-page":"6626","DOI":"10.4049\/jimmunol.172.11.6626","article-title":"Requirement for donor and recipient CD40 expression in cardiac allograft rejection: induction of Th1 responses and influence of donor-derived dendritic cells","volume":"172","author":"Nathan","year":"2004","journal-title":"J Immunol"},{"key":"10.1038\/mtna.2015.40_bib37","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1517\/17425250902877680","article-title":"Antisense oligonucleotide pharmacokinetics and metabolism","volume":"5","author":"Geary","year":"2009","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1038\/mtna.2015.40_bib38","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1021\/jm801294h","article-title":"Short antisense oligonucleotides with novel 2\u2019-4\u2019 conformationaly restricted nucleoside analogues show improved potency without increased toxicity in animals","volume":"52","author":"Seth","year":"2009","journal-title":"J Med Chem"},{"key":"10.1038\/mtna.2015.40_bib39","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/ki.1981.588","article-title":"Changes in glomerular filtration rate during complete ureteral obstruction in rats","volume":"19","author":"Harris","year":"1981","journal-title":"Kidney Int"},{"key":"10.1038\/mtna.2015.40_bib40","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1093\/nass\/nrn280","article-title":"Design, synthesis and evaluation of constrained methoxyethyl (cMOE) and constrained ethyl (cEt) nucleoside analogs","volume":"52","author":"Seth","year":"2008","journal-title":"Nucleic Acids Symposium Series"},{"key":"10.1038\/mtna.2015.40_bib41","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/S0002-9440(10)64239-3","article-title":"A new method for large scale isolation of kidney glomeruli from mice","volume":"161","author":"Takemoto","year":"2002","journal-title":"Am J Pathol"},{"key":"10.1038\/mtna.2015.40_bib42","doi-asserted-by":"crossref","first-page":"F590","DOI":"10.1152\/ajprenal.00324.2003","article-title":"Serial determination of glomerular filtration rate in conscious mice using FITC-inulin clearance","volume":"286","author":"Qi","year":"2004","journal-title":"Am J Physiol Renal Physiol"}],"container-title":["Molecular Therapy - Nucleic Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253116300518?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253116300518?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,16]],"date-time":"2023-08-16T01:16:00Z","timestamp":1692148560000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2162253116300518"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"references-count":42,"alternative-id":["S2162253116300518"],"URL":"https:\/\/doi.org\/10.1038\/mtna.2015.40","relation":{},"ISSN":["2162-2531"],"issn-type":[{"value":"2162-2531","type":"print"}],"subject":[],"published":{"date-parts":[[2015]]},"article-number":"e265"}}